Embera Takes In $4.5M

Embera NeuroTherapeutics, a Sudbury, MA- and Shreveport, LA-based developer of drugs for treating addictions, has added another $4.5 million in Series A financing, the company announced today. The money comes from Embera’s existing backers, Louisiana Ventures, Louisiana Fund I, and Themelios Ventures, as well as other private investors. The funding will go to supporting the company’s drug, EMB-001, through a Phase 1 safety study, so it can advance in clinical trials as a treatment for nicotine dependence and cocaine addiction.

Trending on Xconomy